Primary Chemoablation for Intermediate-Risk Low-Grade Bladder Cancer: New Paradigm or Added Uncertainty? Letter

J Urol. 2023 Dec;210(6):840. doi: 10.1097/JU.0000000000003729. Epub 2023 Sep 28.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Mitomycin
  • Uncertainty
  • Urinary Bladder Neoplasms* / drug therapy
  • Urinary Bladder Neoplasms* / surgery
  • Urinary Bladder*

Substances

  • Mitomycin